Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e. Tuesday, 12th August, 2025 have 1. Approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2025. The Limited Review Report issued by the Statutory Auditors of the Company enclosed herewith. 2. Approved the appointment of Mr. Arvind Vilasrao Sapkal (DIN- 08607096) as a Non- executive Independent Director of the Company, for a Second term of 5 (Five) consecutive years, which is subject to the approval of the shareholders of the Company. 3.Considered and approved the amendment in the Notice for convening the 32nd Annual General Meeting of the Company. 4. Board have approved the proposal to capitalize on any business opportunity in other field that may arise from time to time, provided the said business activity is included in MOA of the Company.